Partner with the Institute of Cancer Research and help people with cancer. Enquire about corporate fundraising today.

All rights reserved. Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP. A Charity, Not for Profit. Company Limited by Guarantee. Registered in England No.

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Our multidisciplinary centres of excellence and strategic collaborations bring a critical mass of leading researchers together from across the ICR, The Royal Marsden and partner institutions to tackle ...

We offer approximately 20 fully funded PhD studentships each year. Our main round opens in October, but we also advertise projects throughout the year. We provide a generous stipend and cover tuition ...

The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact ...

We applied the principle of synthetic lethality to discover a novel strategy for cancer treatment for patients with BRCA1 or BRCA2 gene mutations. We demonstrated that drugs called PARP inhibitors ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...

We provided the first conclusive evidence that the basic cause of cancer is damage to DNA. The discovery changed scientific opinion dramatically and marked a turning point for cancer research. Until ...

With The Royal Marsden we work across several centres to take the results of our research rapidly into the clinic to develop better treatments for cancer patients. We’ve developed collaborations with ...

Professor Chris Bakal’s group uses genomic approaches and computational modelling to understand how complex biochemical signalling networks are ‘rewired’ during the development of cancer. Our goal is ...